Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
Alkem builds case for semaglutide generics leadership
Mint Mumbai
|March 23, 2026
Alkem Laboratories Ltd is positioning itself to lead India’s fast-growing weight-loss drug market
The company has launched semaglutide pen devices priced at ₹1,800 per month for the starter dose.
Alkem Laboratories Ltd is positioning itself to lead India’s fast-growing weight-loss drug market, with its generic versions of semaglutide, a well-trained medical representative network, and extensive market reach, according to Alkem’s chief executive Vikas Gupta.
The Mumbai-based firm is among the country’s top drug-makers that launched generic versions of the weight-loss drug on Saturday, a day after it lost patent exclusivity in India.
Diese Geschichte stammt aus der March 23, 2026-Ausgabe von Mint Mumbai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Mumbai
Mint Mumbai
Investors bet on large market swings to profit this week
Don ko samajana mushkil bhi nahi namumkin bhi hai (Understanding Don is not just difficult, but impossible), quipped market veteran Nilesh Shah, managing director of Kotak Mahindra Asset Management Co., as conflicting statements on the Iran war emanated from US President Donald Trump over the weekend.
2 mins
March 23, 2026
Mint Mumbai
'Writing about issues without specifics creates uncertainty'
The markets were not kind to HDFC Bank after it announced the abrupt exit of its chairman Atanu Chakraborty on 18 March.
3 mins
March 23, 2026
Mint Mumbai
How a temple event is bringing chiefs of Tata Sons, SP together
Ever since the ouster of Shapoorji Pallonji Group scion Cyrus Mistry as Tata Sons chairman in 2016, the two sides have had frosty relations.
2 mins
March 23, 2026
Mint Mumbai
Clean Energy Innovations Take Spotlight at the Technical Session
Day 3 session highlights hydropower stability, biomass solutions and rural EV innovation as key to sustainable energy transition
1 mins
March 23, 2026
Mint Mumbai
REVERENCE LOST IN RELENTLESS FESTIVAL NOISE
On the first day of the Vikram Samvat 2083 (the Hindu new year), I got up a little early.
3 mins
March 23, 2026
Mint Mumbai
Crude thinking: It's a bad idea for the US to toy with oil prices
Manipulating the oil futures market would be much too distortive
3 mins
March 23, 2026
Mint Mumbai
India's weight-loss drug party is roaring, but the regulator wants sanity to prevail
Just when the weight-loss party was kicking into high gear, the drug regulator has made an entry.
3 mins
March 23, 2026
Mint Mumbai
Homeopathy access likely to expand using allopathic retail networks
In a push for alternative medicines, India is planning to direct allopathic drug wholesale dealers to stock and distribute homoeopathy medicines in the world’s third-largest pharmaceutical market by volume, as per two officials and documents reviewed by Mint.
2 mins
March 23, 2026
Mint Mumbai
Tata chip unit raises $735 mn from banks
Dholera land zero-valued; banks want Tatas to retain 51% stake
3 mins
March 23, 2026
Mint Mumbai
Vedanta taps NCLAT on Adani's JAL deal
Anil Agarwal-led Vedanta Ltd has moved the National Company Law Appellate Tribunal (NCLAT) against the approval of Adani Enterprises Ltd’s ₹14,543 crore bid for bankrupt Jaiprakash Associates Ltd (JAL).
3 mins
March 23, 2026
Listen
Translate
Change font size